Strong cannabis stock with real Ten-Bagger potential!

According to the company’s projections, the gross profit (EBITDA) is expected to skyrocket from an estimated C$ 4.1 million in 2019 to a staggering C$ 67.5 million in 2020! The market capitalization is currently only at C$ 31 million – We see several hundred percent upside in the share price! Get in now before the upcoming ‚moon shot‘!

You could have made a lot of money in the cannabis sector in the past, but those who had a bad timing could have lost everything again quickly in the same time.

Cannabisradar.info ensures that you are always in the right place at the right time, and even more importantly, that your depot literally explodes.

With Nabis Holdings Inc., we present today an exceptionally exciting cannabis story for your portfolio. If you want to watch how your fortune multiply, this stock must be in your portfolio!!!

Business model of Nabis:

Nabis Holdings Inc. is a Canadian investment firm focused on investing in high-quality cash-flow generating and strategic assets in various sectors of the cannabis sector. Especially in US states in which are limited cannabis licenses available – with a roadmap for global expansion. The company will focus on investing in all vertically integrated sectors, with a focus on strategic revenue generation, EBITDA and overall growth.

There is no way around Nabis…

Of course, that sounds nice and good, but nobody cares at the end of the day. Much more important is why we probably will make so much money with this stock, if the management delivers in the next 12-18 months! With Nabis you have a real chance of a multibagger! Why? Quite simply, the company’s market capitalization is currently at ridiculous low C$ 31 million – but management expects a real revenue and earnings explosion in the years ahead. When we first saw the estimates, we could not believe it at first – look yourself here:

We made the effort and performed for you, dear readers, some extensive calculations on potential price targets for Nabis Holdings:

Many peer group companies of Nabis Holdings trade between a 10-20 EBITDA multiple. We simulated conservative calculations between 1 and 9 times multiple in the table. Potential price gains of sensational 118-1.859% are mathematically possible with this fundamentally extremely strong cannabis share! Calculate for yourself.

With Nabis you have a real chance of a Ten-Bagger!

Now you have the unique opportunity to realize several hundred percent gains with this cannabis top pick! By getting started with Nabis Holdings, you are now catching the perfect moment you would surely have missed without us. An investment amount of € 5,000 could be worth up to € 50,000.

The stock has consolidated strongly in the last months and is ready to start soaring at any moment. We assume that this will be the case in a timely manner, so you should not hesitate too long, because who wants to jump on a moving train.

Nabis is massively undervalued compared to the peer group – we expect a re-rating and strong price appreciation of the stock!

Highlights, top facts and our assessment to Nabis Holdings:

Nabis Holding is Canadian investment company focused on investing in high quality cash flowing strategic assets in the cannabis sector.
The company focus on strategic revenue generating investments with EBITDA and growth.
Completed private placement offering of debenture units raising gross proceeds of C$35 million in March 2019.
Experienced Management Team: company is led by two of the co-founders of MPX Bioceutical, which was bought by iAnthus for C$ 835 Mio.
Nabis has closed & executed binding LOI’s which let the company expect massive growth in revenues (C$ 14.8 million in 2019 and C$ 167.9 million) and corresponding EBITDA (C$ 4.1 million in 2019 and C$ 67.5 million in 2020)!
Vote of confidence: Management and Insider ownership: 29%
Focussed growth strategy: Footprint in 10 american states by end of 2019 and activities in 18 states within 18 month!
Nabis is evaluating multiple investment opportunities in Israel, the EU & Woldwide – strong positive news flow expected!
Extremly attractive und highly undervalued valuation: share price could easy multiply if the business plan is excectuted successfully!
Cannabis Holding Companies offer diversification & growth potential
Diverse Revenue – Significant geographical reach across states, as well as vertical reach into industry subsets.
Numerous Catalysts – Near-term acquisitions and partnerships could create many near-term catalysts for investors.

Market capitalization as of July 8, 20019: C$ 31 million

Compared to the peer group, the market capitalization of just C$ 31 million at the moment for Nabis is ridiculous low. Because in comparison to many competitors, the company not only swings nice speeches, but does exactly what it promises.

The company is well funded as you can see in the highlights, and a lot of LOI’s have been closed to drive growth in the future. Now it’s all about implementing one project after the other, and that’s exactly where a lot has already been achieved, as you can see from the last press releases.

Sales revenues are expected to increased tenfold compared to 2019 to almost C$ 168 million. But sales is not everything, more important is what profits can be realized and that number could be very impressive. The company expects an EBITDA of almost C$ 70 million in 2020. The market capitalization is currently only at C$ 31 million.

Tell me one stock which has the same potential numbers… i guess you will not find one. It can be assumed that not only sales will increase tenfold but also the price. Now you have it in your own hands to give yourself the golden handshake.

Management with guaranteed success …

We just cannot stress it often enough, everything is just right for this stock. The company has enough cash, the project pipeline is professionally prepared and, finally, the company has a management with a guaranteed success. The company is led by two co-founders of MPX Bioceutical. MPX was acquired by iAnthus for $ 835 million !!!

To our knowledge, this was the largest takeover in the still young cannabis sector so far.
These gentlemen would not have engaged with Nabis if they did not see the potential to make such a performance again. So be there right from the start and take now the chance to multiply your investment !!

After the crash is before the bull market! Such bargains are only available in the current cannabis consolidation / crash – do not hesitate too long. To have an opportunity in front of you to make € 50,000 from an initial investment of € 5,000, you have not too often in life, many even never….No guarantees, but everything is possible.

Name:	Nabis Holdings Inc.
German security number:	A2PLN8
ISIN:	CA6295231014
Equity Ticker Germany:	A2PL
Equity Ticker Canada:	NAB.CN
Last stock price:	0,31 C$

Please note that trade volumes are generally higher on the Canadian main exchange rather than on German stock exchanges. In general, limit orders are preferable to pure ‘cheapest/buy at market’ orders.

We are not investment advisors – please read our risk information / Disclaimer!

Happy Trading wishes your
Cannabisradar-Team

Excerpt of our Legal Notes / Disclaimer

Financial Research & Publication Ltd operates the websites Cannabisradar.de and Cannabisradar.info called „web pages“ below.

The contents of the „web pages“, the newsletters and other publications are prepared with the utmost care. Despite all care in the preparation, Financial Research & Publication Ltd assume no liability or responsibility for the correctness, completeness and timeliness of the information contained in the content provided. Furthermore, the relevance of any price forecasts / price targets is not guaranteed in any way whatsoever. The use of the content of the „web pages“, the newsletters and other publications is at the user’s own risk. The web offer is intended for users resident in the Federal Republic of Germany, Switzerland and Austria. The web page is not intended for users who are resident in countries other than those mentioned above, have been or are otherwise subject to the regulations of other countries. Financial Research & Publication Ltd does not assume any liability or guarantee that the information contained in this web page is in accordance with the laws of other states than the Federal Republic of Germany, Switzerland and Austria.
All publications (eg. interviews, articles, short reports, featured company reports, stock market letters, newsletters, sample portfolios, chart-technical assumptions etc.) are for information purposes only and do not constitute trade recommendations regarding the purchase or sale of the instruments discussed. All publications are not to be equated with professional financial analysis but merely reflect the opinion of the website operator (and / or its internal or external editorial staff or business partners). Our produced content has a journalistic nature. The website operator and the authors of all website content assume no responsibility for the topicality, correctness or completeness of the information contained in the publications. The website operator and the external authors are not investment advisors.
The subject of published financial analysis or website content may be shares of companies that have a low market capitalization. Especially for companies with a low market capitalization, investors often have to expect high volatility or low market liquidity.
The subject of the published content on the websites are mostly stocks, that are associated with major price risks and are therefore unsuitable for inexperienced or risk-averse investors. This is especially true for all Over The Counter (OTC), i.e. the so-called outside of a monitored stock exchange or regulated market. The same applies to shares that are traded on the Australian Stock Exchange (ASX), on Canadian stock exchanges (i.e. Toronto or Vancouver) or on the Alternative Investment Market (AIM), a segment of the London Stock Exchange. The shares we analyzed or feature at our web pages are frequently traded on any of these markets in which they are segments of the highest risk category. Instruments which are traded, are threatened at any time by the possibility of a total loss, high volatility and the possibility of reduced liquidity and marketability in particular due to low trading volumes. High price opportunities are faced with enormous risks.
All of the information contained in the „web pages“, the newsletters or other published content neither constitutes a solicitation nor an offer to sell or purchase any investment or for making other transactions. It is also not a recommendation in the context of investment advice.
Any forecasts or opinions expressed reflect our own, subjective and current views of the publisher and are for guidance and information only. The „web pages“ do not consider specific investment objectives, financial situation or particular needs of individual users. The securities and financial instruments presented on these „web pages“ may not be suitable as an investment instrument for every user. Please do your own Due Dilligence.
Financial Research & Publication Ltd assumes no liability for trade ideas, market forecasts and other information made available. This is in no way a call for individual or general reproduction. The background information, trade ideas, market forecasts and securities analyzes by Financial Research & Publication Ltd published on its „web pages“, does not constitute an offer for sale of the listings handled nor a solicitation to buy or sell shares, but also not of commodities, currencies, other securities or structured and derivative financial products. The versions are based on sources the editor believes to be trustworthy.
Although the conclusions and statements contained in the analysis, publications and market assessments have been drawn with reasonable diligence, we assume no responsibility or liability for errors, omissions or incorrect information. This is also true for all of the opinions expressed by our interlocutors in the interviews, figures and expressions. Before a customer makes investment decisions, he should have carefully gathered information about the opportunities and risks of the investment. A positive performance of a financial product in the past can in no way be an indication of a future performance. The reader is urged to check all information and allegations himself. An investment in the featured, sometimes highly speculative shares should not be made without analyzing and reading the latest balance sheets, assets reports and press releases of the company. Material on this website may contain technical or inaccuracies, typographical errors or omissions, for which we assumes no responsibility. Price forecasts for financial instruments in our stock market bulletins and newsletters do not constitute a financial analysis / investment recommendation, they are based purely on subjective technical chart based forecasts of the author.

Disclosure of Interest:
Information pursuant to Section § 34b of the German Securities Trading Act [WpHG] and to Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse (market abuse regulation)

An individual disclosure regarding securities positions of the publisher and the authors and / or the remuneration of the publisher or the authors by the company or third parties involved in publications are expressly stated in or under the respective publication. This also applies to options and derivatives based on these securities.
The website operator provides companies with marketing and advertising services. We will be compensated for advertising services by these featured companies (sponsors) or by external third parties (e.g. consultants, who have business relationship with the companies). Here is a conflict of interest. Furthermore, a consulting or other service contract may exist or existed between the featured companies promoted on our websites and Financial Research & Publication Ltd, which also constitutes a conflict of interest. Since we can at no time rule out that other media, research provider or stock promotors publish articles or feature our clients during the same period, a symmetrical generation of information and opinion can occur. Nor can it be ruled out that companies that have booked modules to increase market awareness at our websites will not use other service providers in parallel.
We are compensated by featured companies (sponsors) on our website for advertising and maketing services. We are unable to verify all of the data released by public companies or its management. Featured companies are only profiled, we do not recommend stocks to buy or sell. We cannot guarantee all information are accurate and we may make forward looking statements that are uncertain and risky.
Financial Research & Publication Ltd or employees of the Company may at any time conduct buy or sell transactions in the shares of the featured companies (i.e. long or short positions). This also applies to options and derivatives, based on these securities. Those transactions may affect the respective company’s stock price under certain circumstances. Published information on the „web pages“, the newsletters, recommendations, interviews and company presentations are often paid by the respective company or third parties (so-called „third parties“). The „third parties“ include, for example, Investor Relations, Public Relations, Consultants, Brokers and Investors. Financial Research & Publication Ltd may partly directly or indirectly be compensated for the preparation and electronic distribution and other services in cash, and/-or shares / options by the so-called „third party” or direct by featured company. Even if we create each analysis and other content to the best of knowledge and belief and professional standards, we advise you to involve further external sources, such as your local bank or a consultant you trust regarding your investment decisions.
Information and analysis provided is for entertainment, informational and educational purposes only. Nothing in an article, research report, Newsletter, stock report, commentaries interview and other published content constitutes or can be construed as investment advice or an offer or solicitation to buy or sell a stock.
Articles, interviews or other content is based on public information and conversations with Management or company employees. We are unable to verify all of the data released by public companies or its management. Featured companies are only profiled, we do not recommend stocks to buy or sell. We cannot guarantee all information are accurate and reliable. The information may not be complete or correct. We may make forward looking statements that are uncertain and risky.
We require our staff and independent external authors and clients to disclose their positions in individual securities that are mentioned in a publication that they author and that is featured on our website and written content.
IMPORTANT: Although we require our staff and independent external authors and clients to disclose their positions in individual securities that are mentioned in a publication that they author and that is featured on our websites and publications, we cannot and will not guarantee that the information they disclose or fail to disclose is accurate, honest, truthful and complete.
In addition, portions of our websites may contain opinions that are different from other portions of our websites. Our stuff, external authors, clients, advertisers and agents may, from time to time, have long and short positions in, or buy or sell the securities, or derivatives thereof, of companies mentioned in respective website or other published content and may take positions inconsistent with the views expressed in the content.
We may hire third party service providers to electronically disseminate live news and content regarding our clients / our profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer even where such compensation is not disclosed by them.
No guarantee of price data
Financial Research & Publication Ltd does not assume any liability for the accuracy of the charts and data of commodities, currency and equity markets presented in the „web pages“, in the newsletters and all produced content. Displayed prices and data may be time-delayed and out-of-date.

Imprint:
Financial Research & Publication Ltd
20-22 Wenlock Road
London N1 7GU
England

E-Mail: [email protected]
Responsible person: Paul Miller
Tel. +44 20 3608 1991

This was an exerpt of our Disclaimer, you can see our complete risk warnings/Disclaimer here: